BIO-RAD LABORATORIES-A (BIO) Stock Balance Sheet
NYSE:BIO - New York Stock Exchange, Inc. - US0905722072 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 521.40M | 488.10M | 403.81M | 434.00M | 471.00M | |||
| Marketable Securities | 1.14B | 1.18B | 1.20B | 1.36B | 399.00M | |||
| Receivables | 425.00M | 453.00M | 489.00M | 495.00M | 424.00M | |||
| Inventories | 790.00M | 760.00M | 781.00M | 719.00M | 572.00M | |||
| Other Current Assets | 161.00M | 154.00M | 172.00M | 153.00M | 125.00M | |||
| Total Current Assets | 3.04B | 3.03B | 3.05B | 3.16B | 1.99B | |||
| Non-Current Assets | ||||||||
| PPE Net | 682.00M | 689.00M | 724.00M | 680.00M | 716.00M | |||
| Investments And Advances | 4.99B | 4.84B | 7.70B | 8.83B | 14.39B | |||
| Goodwill | 415.00M | 411.00M | 414.00M | 406.00M | 347.00M | |||
| Intangibles | 296.00M | 294.00M | 321.00M | 332.00M | 254.00M | |||
| Other Non-Current Assets | 103.00M | 102.00M | 94.00M | 95.00M | 104.00M | |||
| Total Non-Current Assets | 6.49B | 6.33B | 9.25B | 10.34B | 15.81B | |||
| TOTAL ASSETS | 9.53B | 9.36B | 12.30B | 13.50B | 17.80B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.20M | 1.20M | 490.00K | 0.00 | 0.00 | |||
| Accrued Expenses | 199.00M | 166.00M | 180.00M | 231.00M | 313.00M | |||
| Accounts Payable | 138.00M | 368.50M | 429.55M | 135.00M | 142.00M | |||
| Other Current Liabilities | 169.00M | 178.00M | 197.00M | 202.00M | 225.00M | |||
| Total Current Liabilities | 507.00M | 468.00M | 523.00M | 569.00M | 681.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.20B | 1.20B | 1.20B | 1.20B | 11.00M | |||
| Deferred Taxes/Income | 841.00M | 818.00M | 1.48B | 1.77B | 3.06B | |||
| Other Non-Current Liabilities | 299.00M | 309.00M | 361.00M | 350.00M | 358.00M | |||
| Total Non-Current Liabilities | 2.34B | 2.33B | 3.04B | 3.32B | 3.43B | |||
| TOTAL LIABILITIES | 2.85B | 2.79B | 3.56B | 3.89B | 4.11B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 7.48B | 7.42B | 9.26B | 9.90B | 13.53B | |||
| Additional Paid In Capital | 476.00M | 463.00M | 449.00M | 447.00M | 442.00M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -867.00M | -772.00M | -633.00M | -264.00M | -106.00M | |||
| Other Shareholders' Equity | -419.00M | -542.00M | -337.00M | -457.00M | -181.00M | |||
| Shares Outstanding | 28.00M | 28.00M | 29.00M | 30.00M | 30.00M | |||
| Tangible Book Value per Share | 213.14 | 209.43 | 276.07 | 295.90 | 436.13 | |||
| Total Shareholders' Equity | 6.68B | 6.57B | 8.74B | 9.62B | 13.69B | |||
| TOTAL LIABILITIES AND EQUITY | 9.53B | 9.36B | 12.30B | 13.50B | 17.80B | |||
| Statistics | ||||||||
| Debt/Equity | 0.18 | 0.18 | 0.14 | 0.12 | 0.00 | |||
| Current Ratio | 5.99 | 6.47 | 5.83 | 5.55 | 2.92 | |||
| Return On Assets (ROA) | -22.71% | -19.69% | -5.18% | -26.87% | 23.90% | |||
| Return On Equity (ROE) | -32.40% | -28.07% | -7.29% | -37.73% | 31.09% | |||
| Return On Invested Capital (ROIC) | 2.70% | 2.66% | 2.46% | 2.97% | 2.61% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 3.31% | 3.27% | 2.84% | 3.45% | 2.75% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 3.67% | 3.62% | 3.06% | 3.70% | 2.85% | |||
All data in USD , ROIC based on taxRate of 0.21